291 related articles for article (PubMed ID: 29174331)
1. Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular Reprogramming.
Ruetz T; Pfisterer U; Di Stefano B; Ashmore J; Beniazza M; Tian TV; Kaemena DF; Tosti L; Tan W; Manning JR; Chantzoura E; Ottosson DR; Collombet S; Johnsson A; Cohen E; Yusa K; Linnarsson S; Graf T; Parmar M; Kaji K
Cell Stem Cell; 2017 Dec; 21(6):791-805.e9. PubMed ID: 29174331
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of iPS cell generation and beyond.
Kaji K
Keio J Med; 2017; 66(1):14. PubMed ID: 28356547
[TBL] [Abstract][Full Text] [Related]
3. Polycomb determines responses to smad2/3 signaling in embryonic stem cell differentiation and in reprogramming.
Dahle O; Kuehn MR
Stem Cells; 2013 Aug; 31(8):1488-97. PubMed ID: 23666711
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting Smad2/3 signaling in pluripotent mouse embryonic stem cells enhances endoderm formation by increasing transcriptional priming of lineage-specifying target genes.
Dahle Ø; Kuehn MR
Dev Dyn; 2016 Jul; 245(7):807-15. PubMed ID: 27012147
[TBL] [Abstract][Full Text] [Related]
5. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
[TBL] [Abstract][Full Text] [Related]
6. Progress in the reprogramming of somatic cells.
Ma T; Xie M; Laurent T; Ding S
Circ Res; 2013 Feb; 112(3):562-74. PubMed ID: 23371904
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of miRNA-212/132 improves the reprogramming of fibroblasts into induced pluripotent stem cells by de-repressing important epigenetic remodelling factors.
Pfaff N; Liebhaber S; Möbus S; Beh-Pajooh A; Fiedler J; Pfanne A; Schambach A; Thum T; Cantz T; Moritz T
Stem Cell Res; 2017 Apr; 20():70-75. PubMed ID: 28314201
[TBL] [Abstract][Full Text] [Related]
8. The transcription factor code in iPSC reprogramming.
Deng W; Jacobson EC; Collier AJ; Plath K
Curr Opin Genet Dev; 2021 Oct; 70():89-96. PubMed ID: 34246082
[TBL] [Abstract][Full Text] [Related]
9. [Reprogramming of somatic cells. Problems and solutions].
Schneider TA; Fishman VS; Liskovykh MA; Ponamartsev SV; Serov OL; Tomilin AN; Alenina N
Tsitologiia; 2014; 56(12):869-80. PubMed ID: 25929128
[TBL] [Abstract][Full Text] [Related]
10. Human transcription factors responsive to initial reprogramming predominantly undergo legitimate reprogramming during fibroblast conversion to iPSCs.
Cevallos RR; Edwards YJK; Parant JM; Yoder BK; Hu K
Sci Rep; 2020 Nov; 10(1):19710. PubMed ID: 33184372
[TBL] [Abstract][Full Text] [Related]
11. Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.
Phang RZ; Tay FC; Goh SL; Lau CH; Zhu H; Tan WK; Liang Q; Chen C; Du S; Li Z; Tay JC; Wu C; Zeng J; Fan W; Toh HC; Wang S
Stem Cells Transl Med; 2013 Dec; 2(12):935-45. PubMed ID: 24167318
[TBL] [Abstract][Full Text] [Related]
12. Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.
Velychko S; Adachi K; Kim KP; Hou Y; MacCarthy CM; Wu G; Schöler HR
Cell Stem Cell; 2019 Dec; 25(6):737-753.e4. PubMed ID: 31708402
[TBL] [Abstract][Full Text] [Related]
13. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine.
Xie M; Tang S; Li K; Ding S
Acc Chem Res; 2017 May; 50(5):1202-1211. PubMed ID: 28453285
[TBL] [Abstract][Full Text] [Related]
15. TRANSDIRE: data-driven direct reprogramming by a pioneer factor-guided trans-omics approach.
Eguchi R; Hamano M; Iwata M; Nakamura T; Oki S; Yamanishi Y
Bioinformatics; 2022 May; 38(10):2839-2846. PubMed ID: 35561200
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cell generation from bovine somatic cells indicates unmet needs for pluripotency sustenance.
Pillai VV; Kei TG; Reddy SE; Das M; Abratte C; Cheong SH; Selvaraj V
Anim Sci J; 2019 Sep; 90(9):1149-1160. PubMed ID: 31322312
[TBL] [Abstract][Full Text] [Related]
17. A PIANO (Proper, Insufficient, Aberrant, and NO Reprogramming) Response to the Yamanaka Factors in the Initial Stages of Human iPSC Reprogramming.
Hu K
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370214
[TBL] [Abstract][Full Text] [Related]
18. Synthetic genetic circuits to uncover the OCT4 trajectories of successful reprogramming of human fibroblasts.
Ilia K; Shakiba N; Bingham T; Jones RD; Kaminski MM; Aravera E; Bruno S; Palacios S; Weiss R; Collins JJ; Del Vecchio D; Schlaeger TM
Sci Adv; 2023 Dec; 9(48):eadg8495. PubMed ID: 38019912
[TBL] [Abstract][Full Text] [Related]
19. Human fibroblast reprogramming to pluripotent stem cells regulated by the miR19a/b-PTEN axis.
He X; Cao Y; Wang L; Han Y; Zhong X; Zhou G; Cai Y; Zhang H; Gao P
PLoS One; 2014; 9(4):e95213. PubMed ID: 24740298
[TBL] [Abstract][Full Text] [Related]
20. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
Heng BC; Fussenegger M
Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
